Robert Rosenstein

1.0k total citations
40 papers, 768 citations indexed

About

Robert Rosenstein is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Robert Rosenstein has authored 40 papers receiving a total of 768 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 12 papers in Cardiology and Cardiovascular Medicine and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Robert Rosenstein's work include Platelet Disorders and Treatments (9 papers), Blood properties and coagulation (5 papers) and Neuroscience of respiration and sleep (5 papers). Robert Rosenstein is often cited by papers focused on Platelet Disorders and Treatments (9 papers), Blood properties and coagulation (5 papers) and Neuroscience of respiration and sleep (5 papers). Robert Rosenstein collaborates with scholars based in United States. Robert Rosenstein's co-authors include Leo R. Zacharski, R. Mayeux, Yaakov Stern, Herbert L. Borison, Robert D. Allen, David Parra, L. R. Zacharski, David R. Burgess, Lawrence E. McCarthy and L. Côté and has published in prestigious journals such as New England Journal of Medicine, The Journal of Cell Biology and Blood.

In The Last Decade

Robert Rosenstein

39 papers receiving 707 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Rosenstein United States 14 193 162 144 131 79 40 768
Ming‐Hwang Shyr Taiwan 19 84 0.4× 63 0.4× 157 1.1× 188 1.4× 157 2.0× 50 1.0k
Maria S. Gawryl United States 19 70 0.4× 89 0.5× 53 0.4× 73 0.6× 467 5.9× 42 1.2k
Robert I. Roelofs United States 16 414 2.1× 40 0.2× 74 0.5× 78 0.6× 410 5.2× 29 1.2k
Yung‐Yee Chang Taiwan 18 352 1.8× 40 0.2× 73 0.5× 83 0.6× 212 2.7× 93 1.1k
Kenneth F. Swaiman United States 20 230 1.2× 106 0.7× 39 0.3× 69 0.5× 466 5.9× 76 1.5k
Elena Koustova United States 25 254 1.3× 301 1.9× 43 0.3× 142 1.1× 414 5.2× 57 1.9k
Cinzia Valeria Russo Italy 23 381 2.0× 74 0.5× 46 0.3× 39 0.3× 178 2.3× 61 1.3k
Tor Skärby Sweden 20 97 0.5× 129 0.8× 132 0.9× 114 0.9× 302 3.8× 36 974
H. P. Ludin Switzerland 21 380 2.0× 48 0.3× 94 0.7× 13 0.1× 170 2.2× 51 1.0k
Irene López-Vílchez Spain 16 27 0.1× 240 1.5× 325 2.3× 65 0.5× 86 1.1× 32 832

Countries citing papers authored by Robert Rosenstein

Since Specialization
Citations

This map shows the geographic impact of Robert Rosenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Rosenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Rosenstein more than expected).

Fields of papers citing papers by Robert Rosenstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Rosenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Rosenstein. The network helps show where Robert Rosenstein may publish in the future.

Co-authorship network of co-authors of Robert Rosenstein

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Rosenstein. A scholar is included among the top collaborators of Robert Rosenstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Rosenstein. Robert Rosenstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rosenstein, Robert, et al.. (2015). Use of apixaban after development of suspected rivaroxaban-induced hepatic steatosis; a case report. Blood Coagulation & Fibrinolysis. 26(6). 699–702. 13 indexed citations
2.
Shah, Sachil, David Parra, & Robert Rosenstein. (2013). Acute Myocardial Infarction During Regadenoson Myocardial Perfusion Imaging. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 33(6). e90–5. 21 indexed citations
3.
Rosenstein, Robert & David Parra. (2011). Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.. New England Journal of Medicine. 365(24). 2334; author reply 2335–2334; author reply 2335. 33 indexed citations
4.
Rosenstein, Robert, et al.. (1989). Mast cells in bone remodeling: using a genetically defined mouse model as a clue to human disease.. PubMed. 25(4). 15–25. 2 indexed citations
5.
Fleck, Steven J., J. E. Falkel, E. A. Harman, et al.. (1989). CARDIOVASCULAR RESPONSES DURING RESISTANCE TRAINING. Medicine & Science in Sports & Exercise. 21(Supplement). S114–S114. 2 indexed citations
6.
Sano, M., Yaakov Stern, Julie Williams, et al.. (1989). Coexisting Dementia and Depression in Parkinson's Disease. Archives of Neurology. 46(12). 1284–1286. 76 indexed citations
7.
Mayeux, R., Yaakov Stern, Robert Rosenstein, et al.. (1988). An Estimate of the Prevalence of Dementia in Idiopathic Parkinson's Disease. Archives of Neurology. 45(3). 260–262. 143 indexed citations
8.
Rosenstein, Robert, et al.. (1983). Cyanide Prevents the Inhibition of Platelet Aggregation by Nitroprusside, Hydroxylamine and Azide. Thrombosis and Haemostasis. 50(4). 780–783. 13 indexed citations
9.
Zacharski, Leo R., et al.. (1981). TISSUE FACTOR: A VITAMIN K‐DEPENDENT CLOTTING FACTOR?. Annals of the New York Academy of Sciences. 370(1). 311–324. 4 indexed citations
10.
Rosenstein, Robert, et al.. (1980). pH, PC02and P02in “High-volume” Platelet Concentrates Prepared by Discontinuous-flow Centrifugation and Stored in Polyvinylchloride and Polyethylene Containers. American Journal of Clinical Pathology. 73(3). 397–399. 2 indexed citations
11.
Rosenstein, Robert & Leo R. Zacharski. (1979). The diagnostic value of the aspirin tolerance test. Thrombosis Research. 16(1-2). 219–230. 6 indexed citations
12.
Allen, Robert D., et al.. (1979). Transformation and motility of human platelets: details of the shape change and release reaction observed by optical and electron microscopy.. The Journal of Cell Biology. 83(1). 126–142. 161 indexed citations
13.
Zacharski, Leo R. & Robert Rosenstein. (1977). Comparison of the Reaction-rate and Clot-density Methods for Determination of Plasma Fibrinogen. American Journal of Clinical Pathology. 68(1). 45–52. 7 indexed citations
14.
Borison, Herbert L., et al.. (1977). Arterial hydrogen ion versus CO2 on depth and rate of breathing in decerebrate cats. Respiration Physiology. 30(3). 311–325. 19 indexed citations
15.
Zacharski, Leo R., et al.. (1974). Concanavalin A Inhibition of Tissue Factor (Thromboplastin) Activity. Blood. 44(6). 783–787. 32 indexed citations
16.
Zacharski, Leo R. & Robert Rosenstein. (1974). Clot Retraction in von Willebrand’s Disease. Thrombosis and Haemostasis. 31(3). 519–520. 1 indexed citations
17.
Rosenstein, Robert, Lawrence E. McCarthy, & Herbert L. Borison. (1974). Influence of hypoxia on tidal volume response to CO2 in decerebrate cats. Respiration Physiology. 20(3). 239–250. 14 indexed citations
18.
Rosenstein, Robert, Lawrence E. McCarthy, & Herbert L. Borison. (1973). Rate versus depth of breathing independent of alveolar oxygen in decerebrate cats. Respiration Physiology. 19(1). 80–87. 14 indexed citations
19.
Rosenstein, Robert, Lawrence E. McCarthy, & Herbert L. Borison. (1968). RESPIRATORY EFFECTS OF ETHANOL AND PROCAINE INJECTED INTO THE CEREBROSPINAL FLUID OF THE BRAINSTEM IN CATS. Journal of Pharmacology and Experimental Therapeutics. 162(1). 174–181. 14 indexed citations
20.
Borison, Herbert L., Robert Rosenstein, & W. G. Clark. (1960). EMETIC EFFECT OF INTRAVENTRICULAR APOMORPHINE AFTER ULTRASONIC DECEREBRATION IN THE CAT. Journal of Pharmacology and Experimental Therapeutics. 130(4). 427–430. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ming‐Hwang Shyr Breakdown of academic impact, for papers by Maria S. Gawryl Breakdown of academic impact, for papers by Robert I. Roelofs Breakdown of academic impact, for papers by Yung‐Yee Chang Breakdown of academic impact, for papers by Kenneth F. Swaiman Breakdown of academic impact, for papers by Elena Koustova Breakdown of academic impact, for papers by Cinzia Valeria Russo Breakdown of academic impact, for papers by Tor Skärby Breakdown of academic impact, for papers by H. P. Ludin Breakdown of academic impact, for papers by Irene López-Vílchez
Rankless by CCL
2026